top of page
shutterstock_1839180499.jpg

Solutions for the Biopharma-Industry

I have strong empathy for the rising number of MD and/or PhD graduates who are eager to start their own biotech company with a great idea or invention made during their studies. This, of course, extends to spin-offs from big pharma as well.  For such start-ups my partners and I take care of everything  from defining a sound equity story, advising them to focus on the most promising AND most realistic projects, helping them with the financing, and accompanying and supporting them in all strategic questions. Right from the start we take on crisis management because we know the many pitfalls in any medical-scientific product and project development.

We also focus on clients from big listed biopharma companies. After 10 years of working as a physician, medical investigator, and senior scientist in basic and clinical-oriented research, and with 20 years international working experience as Biotech fund manager and Pharma/Biotech analyst, I have collected a lot of insights. Therefore, I am able to offer convincing solutions for strategic communications to streamline the expectations of all stakeholders such as investors, analysts, licence holders etc. and the company itself, to maintain a healthy balance in their working relationship.

+

Services

We cover a broad spectrum of essential services to assist you with a successful start-up and a continued progress of your biopharma business.

Dienstleistungen
THE
equity story

To create a sound equity story and an easily understandable corporate message, as brilliant ideas need to be communicated effectively. 

THE
humble strategy

To focus on your core competency and a good strategy; avoiding overconfidence and empty promises.

THE
financing

To always give preference to academic grants, institutional investors and venture capital companies specialized in healthcare, which will at the same time be a form of validation.

THE
market awareness

We convince the market of the potential of the project. As such the market is not patient and in times of uncertainty investors may shy away from risky investments, especially in the biotech field.

THE
ongoing companion

Once a specific strategy, operational measures and communications have been agreed upon, we will continue our support and provide long-term business development assistance.

THE
crisis management

We all know how unpredictable outcomes of medical-scientific research and development are, where even minor delays will have a negative impact. We provide support to navigate you through difficult periods.

Would you like to know more about us?

Get in contact with us!

We offer you a first call free of charge to evaluate your business idea
or your actual business situation to decide on whether a repositioning
of your company and/or a rebranding of your product is needed.

+

“I have got to know and appreciate Dr. Michael Nawrath during his PhD thesis in biochemistry. Through his extensive training as a doctor and scientist as well as his many years of experience as a fund manager and pharmaceutical analyst, Dr. Michael Nawrath has built up an enormous basic knowledge of the entire biopharmaceutical sector. This enables him to assess the potential of startups in the health care sector quickly and comprehensively.”

Dr. Jovan Pavlovic, Doctor of Science
Co-lead of the Swiss Covid Reference Laboratory of the University of Zurich, previously Group Leader, Medical Virology, University of Zurich

Kontakt

Contact

Thank you for your message!

Nawrath BrightSpots

Schulweg 20

8706 Meilen

Switzerland

Phone:

+41 (0) 78 745 28 09

  • LinkedIn

© 2022 Nawrath BrightSpots

bottom of page